COVID-19: Our series of regulatory legislation trackers for the Life Sciences & Healthcare industry

By Mark Hilton, Marc Martens, Sally Shorthose


COVID-19 presents an unprecedented challenge to the global life sciences industry. Members of our International Life Sciences & Healthcare team, lawyers who have a wealth of hands-on experience and strong relationships with regulatory bodies, have worked together to provide an update in the form of a Q&A for each of the countries we are located. This update aims to provide guidance on the responses of EU and Asia-Pac regulators in the areas of clinical trials, medical devices, market access, public procurement and compulsory licensing.

Today we release the first two updates, watch this space for the others coming very soon!

COVID-19: Legislation Tracker for Medical Devices, read here

COVID-19: Legislation Tracker for Clinical Trials, read here